Related Experiment Video
Updated: Mar 31, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019
Highly Efficient SiRNA Delivery Mediated by Cationic Helical Polypeptides and Polypeptide-Based Nanosystems
Lichen Yin1, Nan Zheng2, Jianjun Cheng3
1Institute of Functional Nano & Soft Materials (FUNSOM) & Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, 199 Ren-Ai Rd, Suzhou, Jiangsu, 215123, China. lcyin@suda.edu.cn.
This study introduces cationic helical polypeptides and nanosystems for effective small interfering RNA (siRNA) delivery. These systems enable efficient gene silencing via oral administration, overcoming a major hurdle in RNAi therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Nanotechnology
Background:
- RNA interference (RNAi) is a powerful gene regulation mechanism.
- Effective delivery of small interfering RNA (siRNA) into target cells remains a significant challenge for therapeutic applications.
Purpose of the Study:
- To develop and evaluate novel cationic helical polypeptides and polypeptide-based nanosystems for enhanced siRNA delivery.
- To demonstrate the efficacy of these systems for in vitro and in vivo gene silencing, particularly through oral administration.
Main Methods:
- Synthesis and characterization of cationic helical polypeptides and polypeptide-based nanosystems.
- In vitro assessment of siRNA complexation, cellular uptake, and gene silencing efficiency.
- In vivo evaluation of siRNA delivery and therapeutic effects following oral administration in relevant models.
Main Results:
- Cationic helical polypeptides and their derived nanosystems effectively complexed siRNA.
- High transfection efficiency and potent gene silencing were observed in vitro.
- Successful in vivo delivery and gene silencing were achieved via oral administration, demonstrating therapeutic potential.
Conclusions:
- Cationic helical polypeptides and polypeptide-based nanosystems represent a promising platform for safe and effective siRNA delivery.
- Oral administration of these nanocarriers offers a viable strategy for systemic RNAi-based therapies.
- This approach addresses a critical barrier, paving the way for broader clinical translation of RNAi technology.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Modified-Release Drug Delivery Systems: Site-Targeted
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...

